Immunological and Autoimmune Disorders

Notizia - Recent Pharma, Healthcare and Biotech Happenings

CE Mark to Ibex’s Gastric Cancer Detection System; Senseonics’s Eversense E3 Continuous Glucose Monitoring System; NEUSPERA’s NUVELLA SYSTEM; Conformal Medical Initiates CONFORM Pivotal Trial; Meridian Launches New qPCR Master Mixes for Stool Samples; Sentinel Diagnostics Launches SENTiFIT 800

Conformal Medical Announces Launch of CONFORM Pivotal Trial On June 17, 2022, Conformal Medical Inc, is a medical device company manufacturing devices to avoid strokes in patients with non-valvular atrial fibrillation and developing next-generation LAAO technology. Its exclusive technology is intended to make left atrial appendage closure on the same day, by single operator procedure and the company was founded in 2016. The company announced the launch of the CONFORM pivotal trial with the enrollment of first patients at two United States locations. To support U.S. Food and Drug Administration (FDA) pre-market approval, the investigational device exemption (IDE)...

Explore More...

peanut-allergy-market-size-share-trends-prevalence-therapies-therapeutics-drugs

Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchard gene therapy benefits kids

recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology

Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

recent-pharma-biotech-news-updates-for-verily-janssen-avrobio

Verily – Janssen collaboration; Enhancing the response in pancreatic cancer; Avrobio gene therapy eradicates toxic substrate; Gut microbiome responsible for Multiple Sclerosis

recent-pharma-biotech-happenings-for-bms-prothena-canon-medical-immunovant

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs

Horizon, Viela Deal; Concert Schizophrenia Drug Flop; Gilead, Gritstone Deal

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

Hemophagocytic Lymphohistiocytosis Treatment Market

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Immunological and Autoimmune Disorders

CE Mark to Ibex’s Gastric Cancer Detection System; Senseonics’s Eversense E3 Continuous Glucose Monitoring System; NEUSPERA’s NUVELLA SYSTEM; Conformal Medical Initiates CONFORM Pivotal Trial; Meridian Launches New qPCR Master Mixes for Stool Samples; Sentinel Diagnostics Launches SENTiFIT 800

Peanut Allergy Market Outlook: The Market Size Growth Sees Major Thrusts

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies

Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M

Essential Demands Impinge the Evolving Adult-onset Still’s Disease Treatment Market

Is Antibody-mediated Rejection a Roadblock to Organ Transplantation?

Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchard gene therapy benefits kids

Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis program; Biogen offer access to experimental ALS med

Kinase Inhibitors: Challenging the established Biologics as the new standard of care in autoimmune diseases?

More Views & Analysis

A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers

Hemophilia B Market: How Pipeline Therapies are Transforming the Treatment Hemisphere?

A Royal Disease: Hemophilia

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Verily – Janssen collaboration; Enhancing the response in pancreatic cancer; Avrobio gene therapy eradicates toxic substrate; Gut microbiome responsible for Multiple Sclerosis

Plaque psoriasis drug outshines in phase III trial; Immunovant announces pause in trial of IMVT-1401; Prothena brings AL amyloidosis drug back; Canon Medical expands its MRI AI programs

Horizon, Viela Deal; Concert Schizo Drug Flop; Gilead Deals with Arcus and Gritstone

A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth

Subscribe to our Updates

Daily

Weekly

Monthly